Drug · DIN 02540673
BRIMONIDINE
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since September 1, 2023.
- Drug Identification Number (DIN)
- 02540673
- Company (DIN owner)
- Micro Labs LimitedBangalore, Karnataka, India
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Ophthalmic
- Therapeutic class (ATC)
- Brimonidine S01EA05
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| BRIMONIDINE TARTRATE | 0.2 % | W/V |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 1, 2023: NOC 31540Abbreviated New Drug Submission (ANDS)
Other DINs named BRIMONIDINE
- DIN 02562316 · Marketed
- DIN 02249456 · Cancelled Pre Market